StemCells Company Profile (NASDAQ:STEM)

About StemCells

StemCells logoStemCells, Inc. (StemCells) is engaged in the research, development and commercialization of stem cell therapeutics. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies. Its lead product development program is its central nervous system (CNS) program, in which it is developing applications for HuCNS-SC cells, its human neural platform technology. It is in clinical development with its HuCNS-SC cells for a range of diseases and disorders of the central nervous system, which consists of the brain, spinal cord and eye. It is conducting a Phase I/II clinical trial to evaluate the safety and preliminary efficacy of its HuCNS-SC cells as a treatment for dry age-related macular degeneration (AMD). It has conducted a Radiant Study, which is a Phase II randomized, controlled proof-of-concept study, designed to evaluate both the safety and efficacy of its HuCNS-SC cells for the treatment of geographic atrophy (GA).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: STEM
  • CUSIP:
Key Metrics:
  • Previous Close: $1.41
  • 50 Day Moving Average: $1.30
  • 200 Day Moving Average: $1.76
  • 52-Week Range: $0.33 - $7.56
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.87
  • P/E Growth: 0.00
  • Market Cap: $16.93M
  • Outstanding Shares: 12,006,000
  • Beta: 0.1
Profitability:
  • Net Margins: -24,432.38%
  • Return on Equity: -970.13%
  • Return on Assets: -136.98%
Debt:
  • Current Ratio: 0.46%
  • Quick Ratio: 0.46%
Additional Links:
Companies Related to StemCells:

Analyst Ratings

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $15.86 (1,024.96% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetDetails
9/14/2016S&P Equity ResearchLower Price Target$1.57 -> $1.31View Rating Details
5/31/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
5/10/2016Rodman & RenshawReiterated RatingBuyView Rating Details
3/28/2016Chardan CapitalReiterated RatingBuy$12.00 -> $6.00View Rating Details
12/30/2015HC WainwrightLower Price TargetBuy$25.20 -> $18.00View Rating Details
9/2/2015Royal Bank Of CanadaReiterated RatingBuyView Rating Details
8/10/2015Cantor FitzgeraldReiterated RatingBuy$24.00View Rating Details
5/6/2015Ascendiant Capital MarketsReiterated RatingBuy$18.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for StemCells (NASDAQ:STEM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/6/2016        
3/23/2016Q4($0.09)($0.07)ViewListenView Earnings Details
11/2/2015($0.10)($0.09)ViewN/AView Earnings Details
8/6/2015Q215($0.09)($0.09)ViewListenView Earnings Details
5/5/2015Q1($0.14)($0.11)ViewListenView Earnings Details
3/16/2015Q4($0.12)($0.14)$220.00 million$883.00 millionViewListenView Earnings Details
11/5/2014($0.13)($0.11)ViewN/AView Earnings Details
8/12/2014Q2($0.14)($0.22)ViewListenView Earnings Details
5/14/2014Q1($0.12)($0.14)$0.24 million$0.34 millionViewListenView Earnings Details
3/12/2014Q4($0.13)($0.13)$0.22 million$0.31 millionViewListenView Earnings Details
5/9/2013Q113($0.13)($0.17)$0.29 million$0.28 millionViewListenView Earnings Details
3/21/2013Q412($0.14)($0.07)$0.31 million$0.21 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for StemCells (NASDAQ:STEM)
Current Year EPS Consensus Estimate: $-2.71 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS

Dividends

Dividend History for StemCells (NASDAQ:STEM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for StemCells (NASDAQ:STEM)
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 5.43%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/29/2015Kenneth Blair StrattonGeneral CounselSell104,549$0.45$47,047.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for StemCells (NASDAQ:STEM)
DateHeadline
News IconHC Stocks Broker Alerts! Thermo Fisher Scientific Inc. (TMO), StemCells Inc (NASDAQ:STEM) - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 26 at 11:30 AM
News IconStock to Watch: EP Energy Corporation (NYSE:EPE), StemCells, Inc. (NASDAQ:STEM) - Newburgh Press (NASDAQ:STEM)
newburghpress.com - September 26 at 11:30 AM
News IconTrading the Biotech News: Heat Biologics, Inc. (NASDAQ:HTBX), StemCells Inc. (NASDAQ:STEM) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - September 26 at 11:30 AM
News IconUnder the Microscope, Zeroing in at StemCells Inc. (NASDAQ:STEM) - Duncan Research (NASDAQ:STEM)
www.duncanindependent.com - September 22 at 7:07 PM
News IconHC Stocks Midpoint! StemCells Inc (STEM), Johnson & Johnson (NYSE:JNJ) - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 22 at 7:07 PM
News IconSanofi Files Suit in U.S. to Defend Paten Rights on Lantus® and Lantus® Solostar® (NASDAQ:STEM)
www.bioportfolio.com - September 19 at 11:31 AM
News Icon$CSCO & $STEM - Cisco Systems, Inc. (NASDAQ:CSCO) & StemCells Inc (NASDAQ:STEM) News Review - Money News (NASDAQ:STEM)
www.newsismoney.com - September 17 at 6:55 PM
News IconTrading the Biotech News: StemCells Inc. (NASDAQ:STEM), Mast Therapeutics, Inc. (NYSEMKT:MSTX) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - September 17 at 6:55 PM
News IconNoticeable Stock: StemCells Inc (NASDAQ:STEM) - Post Registrar (NASDAQ:STEM)
postregistrar.com - September 17 at 6:55 PM
News IconInduced Pluripotent Stem Cells Market 2016: Hepatocytes, Fibroblasts, Keratinocytes (NASDAQ:STEM)
www.medgadget.com - September 16 at 11:03 AM
News IconShares Climbing Higher Session: StemCells Inc. (NASDAQ:STEM) - Post News (NASDAQ:STEM)
www.kentuckypostnews.com - September 14 at 7:40 PM
News IconHC Trending Hot Stocks= Arrowhead Pharmaceuticals Inc (ARWR), StemCells Inc (NASDAQ:STEM) - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 14 at 11:50 AM
News IconAnalysts Place StemCells, Inc. (NASDAQ:STEM) Under the Lens of the Microscope - Post News (NASDAQ:STEM)
www.kentuckypostnews.com - September 12 at 7:01 PM
News IconHC Stocks Impression= Amgen, Inc. (NASDAQ:AMGN), StemCells ... - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 9 at 7:06 PM
News IconHC Stocks Updates= StemCells Inc (STEM), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 8 at 7:09 PM
News IconState Stem Cell Institute Still Conflicted (NASDAQ:STEM)
www.mygovcost.org - September 7 at 11:12 AM
marketwired.com logoRegenerative Medicine Foundation Appoints Martin McGlynn to Board of Directors (NASDAQ:STEM)
www.marketwired.com - September 7 at 11:12 AM
News IconStem cell company paid $443,500 to former head of state agency that funds research (NASDAQ:STEM)
www.sacbee.com - September 2 at 12:24 PM
News IconHC Stocks Indications - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), StemCells Inc (NASDAQ:STEM) - share market updates (press release) (NASDAQ:STEM)
sharemarketupdates.com - September 1 at 10:41 AM
News IconLegging Run Stock in Volatile Measures: Abbott Laboratories (NYSE:ABT), StemCells Inc. (NASDAQ:STEM) - Seneca Globe (NASDAQ:STEM)
www.senecaglobe.com - August 31 at 11:55 AM
News IconNews review of 2 biotech stocks: StemCells Inc. (NASDAQ:STEM), CytRx Corporation (NASDAQ:CYTR) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - August 31 at 11:55 AM
News IconNews review of 2 biotech stocks: Clovis Oncology, Inc. (NASDAQ:CLVS), StemCells Inc. (NASDAQ:STEM) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - August 30 at 10:50 AM
News IconHot Biotech Stocks Recap: StemCells (NASDAQ:STEM), Hemispherx Biopharma (NYSEMKT:HEB) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - August 29 at 11:48 AM
News IconNews Buzz: Sirius XM Holdings Inc.(NASDAQ:SIRI), StemCells Inc(NASDAQ:STEM) - NYSE Journal (press release) (NASDAQ:STEM)
stockznews.com - August 24 at 10:41 AM
News IconTime To Put On The Watch List? - StemCells Inc. (NASDAQ:STEM), CytRx Corporation (NASDAQ:CYTR) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - August 24 at 10:41 AM
News IconStemCells Inc (NASDAQ:STEM): This One 8K Extract Is The Only Thing That Matters (NASDAQ:STEM)
streetregister.com - August 23 at 7:43 PM
finance.yahoo.com logoSTEMCELLS INC Financials (NASDAQ:STEM)
finance.yahoo.com - August 23 at 7:43 PM
News IconStemCells Inc.'s (STEM): Stock in Focus - Hot Stocks Point (NASDAQ:STEM)
www.hotstockspoint.com - August 23 at 12:09 PM
News IconVolatile Movements - Twenty-First Century Fox (NASDAQ:FOXA), StemCells Inc (NASDAQ:STEM) - Money News (press release) (NASDAQ:STEM)
www.newsismoney.com - August 23 at 12:09 PM
News IconBiotech Stocks Worth a Closer Look: StemCells Inc. (NASDAQ:STEM), Gilead Sciences Inc. (NASDAQ:GILD) - The Voice Registrar (NASDAQ:STEM)
voiceregistrar.com - August 23 at 12:09 PM
benzinga.com logo12 Biggest Mid-Day Losers For Friday - Benzinga (NASDAQ:STEM)
www.benzinga.com - August 20 at 7:07 PM
News IconStemCells CEO, CFO And Three Other Directors Resigned After Merger (NASDAQ:STEM)
stocknewsusa.com - August 19 at 10:33 AM
streetinsider.com logoStemCells (STEM), Microbot Medical Affirm Entering Merger Agreement (NASDAQ:STEM)
www.streetinsider.com - August 18 at 7:51 PM
wsj.com logoIt’s Even Less Volatile in the Stock Market Than the VIX Suggests (NASDAQ:STEM)
blogs.wsj.com - August 17 at 7:56 PM
thestreet.com logoOne Reason Why StemCells (STEM) Stock Is Down Today (NASDAQ:STEM)
www.thestreet.com - August 17 at 7:56 PM
thestreet.com logoStemCells (STEM) Stock Plummets, CEO, CFO Resign (NASDAQ:STEM)
www.thestreet.com - August 17 at 7:56 PM
seekingalpha.com logoStemCells to be taken private by Israel's Microbot Medical - Seeking Alpha (NASDAQ:STEM)
seekingalpha.com - August 17 at 10:35 AM
marketwatch.com logoStemCells stock increases more than sixfold on news of merger with Microbot Medical - MarketWatch (NASDAQ:STEM)
www.marketwatch.com - August 17 at 10:35 AM
News IconMarket Report, "StemCells, Inc. (formerly CytoTherapeutics, Inc.)", published (NASDAQ:STEM)
reports.pr-inside.com - August 16 at 7:42 PM
News IconStemCells Stock Increases More Than Sixfold On News Of Merger With Microbot Medical (NASDAQ:STEM)
www.foxbusiness.com - August 16 at 7:42 PM
4-traders.com logoSTEMCELLS INC : Other Events (form 8-K) (NASDAQ:STEM)
www.4-traders.com - August 16 at 7:42 PM
News IconStemCells (STEM) Stock Price Surges on Merger Announcement (NASDAQ:STEM)
www.economiccalendar.com - August 16 at 7:42 PM
streetinsider.com logoStemCells (STEM) Enters Merger Agreement with Microbot Medical (NASDAQ:STEM)
www.streetinsider.com - August 16 at 7:42 PM
biz.yahoo.com logoSTEMCELLS INC Files SEC form 8-K, Other Events (NASDAQ:STEM)
biz.yahoo.com - August 16 at 7:42 PM
globenewswire.com logoStemCells, Inc. and Microbot Medical Ltd. Announce Strategic Merger - GlobeNewswire (press release) (NASDAQ:STEM)
globenewswire.com - August 16 at 10:54 AM
publicnow.com logoStemCells, Inc. and Microbot Medical Ltd. Announce Strategic Merger (NASDAQ:STEM)
www.publicnow.com - August 16 at 10:54 AM
reuters.com logoBRIEF-Stemcells says respective boards of co and Microbot approved merger agreement (NASDAQ:STEM)
www.reuters.com - August 15 at 7:57 PM
marketwatch.com logo10-Q: STEMCELLS INC (NASDAQ:STEM)
www.marketwatch.com - August 15 at 7:57 PM
biz.yahoo.com logoSTEMCELLS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:STEM)
biz.yahoo.com - August 15 at 7:57 PM
biz.yahoo.com logoSTEMCELLS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Ag (NASDAQ:STEM)
biz.yahoo.com - August 15 at 7:57 PM

Social

StemCells (NASDAQ:STEM) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff